Skip to main content

2 Bay Area biotechs set to test IPO market: Virobay, Atara Biotherapeutics

The Bay Area's fourth-quarter IPO season swings back into action with a pair of biotech offerings this week from Atara Biotherapeutics and Virobay...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.